OLD Category: signatures

Targeted Transcriptomic Analyses of RNA Isolated from Formalin-Fixed and Paraffin-Embedded Human Menisci

• Monibi FA, Pannellini T, Croen B, Otero M, Warren R, Rodeo SA

New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT

• Cottereau AS, Meignan M, Nioche C, Clerc J, Chartier L, Vercellino L, Casasnovas O, Thieblemont C, Buvat I

MAIT cells regulate NK cell-mediated tumor immunity

• Petley EV, Koay HF, Henderson MA...Godfrey DI, Beavis PA, Darcy PK

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

• Lal JC, Townsend MG, Mehta AK, Oliwa M, Miller E, Sotayo A, Cheney E, Mittendorf EA, Letai A, Guerriero JL

Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?

• Farag KI, Makkouk A, Norian LA

Tumor suppressor immune gene therapy to reverse immunotherapy resistance

• Chada S, Wiederhold D, Menander KB, Sellman B, Talbott M, Nemunaitis JJ, Ahn HM, Jung BK, Yun CO, Sobol RE

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma

• Goedegebuure R, Harrasser M, de Klerk L...Bass A, De Gruijl T, Derks S

Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens

• Haley L, Parimi V, Jiang L...Long P, Zou YS, Gocke CD

Hepatocyte growth factor pathway expression in breast cancer by race and subtype

• Jones GS, Hoadley KA, Olsson LT...Nichols HB, Olshan AF, Troester MA

Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis

• Zeng Z, Li J, Zhang J, Li Y, Liu X, Chen J, Huang Z, Wu Q, Gong Y, Xie C

Predicting molecular phenotypes from histopathology images: a transcriptome-wide expression-morphology analysis in breast cancer

• Wang Y, Kartasalo K, Weitz P, Acs B, Valkonen M, Larsson C, Ruusuvuori P, Hartman J, Rantalainen M

Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

• Bernard S, Ghesquieres H, Casasnovas RO...Copie-Bergman C, Haioun C, Thieblemont C